| 标题 |
[高分]
Ublituximab, a Novel, Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) Relative to Other Anti-CD20 mAbs Ublituximab是一种新型糖工程抗CD20单克隆抗体(mAb),相对于其他抗CD20 mAb,显示出增强的抗体依赖性细胞毒性(ADCC)
|
| 网址 | |
| DOI |
10.1212/WNL.000000000020308
doi
|
| 求助人 | |
| 下载 |